FDA Clearance Tracker · P030016
VISIAN ICL (IMPLANTABLE COLLAMER LENS)
Last checked: Nov 20, 2026Latest source record: Dec 22, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2005
Approved
Time to decision
959 days
Received May 8, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P030016
- Device name
- VISIAN ICL (IMPLANTABLE COLLAMER LENS)
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- May 8, 2003
- Decided
- Dec 22, 2005
- Decision
- Approved
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 45 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Lens, intraocular, phakic (MTA)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE VISIAN ICL (IMPLANTABLE COLLAMER LENS) MODELS MICL12.1, MICL12.6, MICL13.2 AND MICL13.7. THE DEVICE IS INDICATED FOR ADULTS 21-45 YEARS OF AGE: 1) TO CORRECT MYOPIA RANGING FROM -3.0 DIOPTERS TO <=-15.0 DIOPTERS WITH LESS THAN OR EQUAL TO 2.5 DIOPTERS OF ASTIGMATISM AT THE SPECTACLE PLANE; 2) TO REDUCE MYOPIA RANGING FROM GREATER THAN -15.0 DIOPTERS TO -20.0 DIOPTERS WITH LESS THAN OR EQUAL TO 2.5 DIOPTERS OF ASTIGMATISM AT THE SPECTACLE PLANE; AND 3) WITH AN ANTERIOR CHAMBER DEPTH (ACD) 3.00 MM OR GREATER, AND A STABLE REFRACTIVE HISTORY WITHIN 0.5 DIOPTER FOR 1 YEAR PRIOR TO IMPLANTATION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MTA. The earliest in FDA's data is P030028, decided Sep 10, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
- Visian Toric ICL (IMPLANTABLE COLLAMER LENS)PMA supplement
P030016-S001 · Decided Sep 13, 2018 · 4,521 days after receipt · Panel Track
Device type: Phakic toric intraocular lens (QCB) · Ophthalmology
K172375 · Decided Sep 6, 2017 · 30 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.